Literature DB >> 22747854

Predictive utility of blood pressure, waist circumference and body mass index for metabolic syndrome in patients with schizophrenia in Singapore.

Milawaty Nurjono1, Jimmy Lee.   

Abstract

AIMS: This study aims to examine and compare the predictive utility of blood pressure (BP), waist circumference (WC) and body mass index (BMI), and to determine optimal cut-off values in prediction of metabolic syndrome (MetS) in patients with chronic schizophrenia.
METHODS: About 100 patients with chronic schizophrenia were recruited. BMI and BP were measured and laboratory tests to evaluate patients' high-density lipoprotein cholesterol, triglycerides and glucose levels were performed. Presence of MetS was examined according to AHA/NHLBI guidelines. Predictive utility of BP, WC and BMI was examined using receiver operating curve and discriminant indices were determined accordingly.
RESULTS: Forty-six (46%) patients were identified to have MetS. BMI of ≥23 kg m(-2) was most accurate (AUC = 0.83, P < 0.001), with sensitivity of 93.5%, specificity of 48.1%, positive predictive value of 60.6% and negative predictive value of 92.9% in identifying MetS.
CONCLUSION: This finding has immediate and significant clinical implications in the local population with schizophrenia.
© 2012 Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22747854     DOI: 10.1111/j.1751-7893.2012.00384.x

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  5 in total

1.  Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan.

Authors:  Norio Sugawara; Norio Yasui-Furukori; Manabu Yamazaki; Kazutaka Shimoda; Takao Mori; Takuro Sugai; Hiroshi Matsuda; Yutaro Suzuki; Yuji Ozeki; Kurefu Okamoto; Toyoaki Sagae; Toshiyuki Someya
Journal:  Neuropsychiatr Dis Treat       Date:  2020-09-30       Impact factor: 2.570

2.  A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls.

Authors:  Davy Vancampfort; Martien Wampers; Alex J Mitchell; Christoph U Correll; Amber De Herdt; Michel Probst; Marc De Hert
Journal:  World Psychiatry       Date:  2013-10       Impact factor: 49.548

3.  Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses.

Authors:  Brian J Miller; Andrew Mellor; Peter Buckley
Journal:  Brain Behav Immun       Date:  2012-09-11       Impact factor: 7.217

Review 4.  Metabolic syndrome in schizophrenia.

Authors:  Nidhi Malhotra; Sandeep Grover; Subho Chakrabarti; Parmanand Kulhara
Journal:  Indian J Psychol Med       Date:  2013-07

5.  Risk Factors of Metabolic Syndrome in Community-Dwelling People with Schizophrenia.

Authors:  Min Jung Sun; Mi Heui Jang
Journal:  Int J Environ Res Public Health       Date:  2020-09-14       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.